Clinical Trial Seeks To Improve Patient Treatment For Crohn’s Disease
Robarts Clinical Trials at The University of Western Ontario in London, Canada, has been awarded a 4.7 million dollar grant to conduct a randomized controlled trial evaluating treatment options for Crohn’s disease. The outcome is expected to lead to a more streamlined treatment path and better disease management for patients…
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.